The immune system contains two different but intersecting mechanisms that recognize foreign antigens. One involves recognition of intact proteins and other large antigens, while the other involves processing of protein antigen and the presentation of some of the resulting peptides in association with a major histocompatibility complex antigen in order to be recognized. The proteins involved in antigen recognition and presentation, antibodies, major histocompatibility antigens, and T-cell receptors have been the focus of considerable structural investigation, Despite a recent determination of the structure of a human leukocyte antigen (l), most of our present structural information is about antibodies, and in particular their Fabs. The three-dimensional structures of antibodies have been known for some time based on x-ray diffraction studies on myeloma proteins, some of which have defined specificity for haptens (for reviews see Refs. 2 and 3). Recently our knowledge of the nature of the interaction between antibodies and protein antigens has been significantly advanced by the crystal structure determinations from three laboratories of four complexes of antibody Fabs with their protein antigens. In what follows we shall summarize these results and discuss how these new data relate to other work in the field.
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The early x-ray work on antibodies from myelomas helped to establish the structural basis of antibody function (reviewed in Refs. 2 and 3). The antibody molecule was demonstrated to be a flexible association of light and heavy chains with each chain folded into several characteristic globular domain structures of approximately 110 amino acid residues originally predicted on the basis of sequence analysis by Edelman et al. (4, 5) . The domains are tightly joined in pairs to form functional modules such as VH:VL and CH1:CL. The antigen binding site was shown to be at the tip of the Fab where the six hypervariable regions (6) of VH and VL were brought together to form a continuous hypervariable surface. The amino acids that make up the VH:VL interface consist of conserved residues as well as hypervariable residues (7, 8) , and it has been proposed that these may modulate the relative positions of VH and VL, thus altering the specificity of the antibody (9).
The domain structure of the antibody molecule is a 8-barrel consisting of seven (in constant domains) or nine (in variable domains) antiparallel 8-strands. This fold is often used by other proteins of the immune system. Recent x-ray analysis of a human leukocyte antigen molecule (1) together with the previous structure determination of &-microglobulin (10) showed that both of these contain domains that closely resemble the antibody domain. Amino acid sequence analysis strongly suggests that Class I1 major histocompatibility antigens, Thy-I antigens, T-cell receptors, polymeric immunoglobulin receptors, the CD-4 and CD-8 antigens of T-cells (11), and the neural cell adhesion molecule (12), among others, contain immunoglobulin domain structures.
Because the early x-ray analysis of antibody structure was restricted to myeloma proteins, the antigenic determinants that were studied were either rather small molecules such as phosphocholine (13), dinitrophenyl, and vitamin K, derivatives (14) or were repeating long chain carbohydrate polymers. In the case of the two mouse proteins, McPC603 and 5539, sequence analyses on a number of antibodies with similar specificities left little doubt that the threedimensional structures observed and the mode of binding to the antigenic determinant were representative for those antibodies. However, crystal structure analysis of the binding of small molecule haptens (phosphocholine and vitamin K, derivative) left unanswered whether these results could be applied to much larger protein antigens. With monoclonal antibody technology it has become possible to select antibodies against specific protein antigens, and recently several x-ray diffraction studies have been reported on complexes of antibody Fabs with their protein antigens. These investigations have considerably broadened the data base for antibody structures and have provided new data on the mechanisms of antibody specificity and diversity.
Scope of This Review
As a result of this work we can now begin to address a number of questions concerning antibody-antigen interactions. 1) Is the antigenic determinant (epitope) made up of predominantly continuous segments of polypeptide chain or is it the result of the juxtaposition of a number of segments from different parts of the protein sequence? 2) What is the nature and extent of complementarity at the antibodyantigen interface? 3) Is charge neutralization a significant factor in recognition and in stabilization of the antibody-antigen complex? 4) What is the role of mobility and accessibility in defining the antigenic determinant? 5) How successful have been the serological attempts to map epitopes? 6) Is there any significant conformational change upon binding in either the antibody or the antigen or do they interact passively in a "lock-and-key" mode? 7) Is the flexibility observed at the junction between the VH:VL and CH1:CL modules a signal transduction mechanism or is it simply an expression of flexibility between more rigid components?
Many of the questions about protein-protein interactions have been extensively studied in other systems such as oligomeric proteins and enzyme-inhibitor complexes. However, the unique features of the antibody combining site require that these questions be re-examined for these antibody-antigen complexes. Given that there are about log different antibody specificities and that only four complexes have been investigated so far, it would be inadvisable to make sweeping generalizations. However, there are some conclusions that can be drawn from the existing data.
Description of the Complexes
The four structures on which this review is based consist of the Fabs of three antibodies to hen egg white lysozyme complexed with the lysozyme (15-17)' together with a fourth complex between an Fab, NC41, and the neuraminidase from influenza virus (18). The three anti-lysozymes, D1.3, HyHEL-5, and HyHEL-10, bind to different parts of the lysozyme surface (Fig. 2) , although there is a small overlap between the epitopes (those parts of the lysozyme that are in contact with the antibody) of HyHEL-10 and D1.3. The three epitopes cover altogether approximately half the total surface area of the lysozyme. The association constants for the three antibody-lysozyme complexes are in the range from lo' to lo9.
The amino acid residues that make up the epitopes are summarized in Table I for lysozyme, where it is clear that they are located in several discrete segments of polypeptide chain. These are contiguous on the surface as a result of the folding of the protein. A few long segments do occur, such as the sequence from 41 to 53 in the epitope for HyHEL-5, but mostly the segments are fairly short. A similar situation with discontinuous segments also occurs in the neuraminidase-Fab complex, i.e. residue numbers 368-370, 400-403, 430-434, and portions of 325-350 (18) .
In all four examples the residues from the antibody that are in contact with the antigen come from all six complementarity determining regions with the possible exception of the first CDR2 in the ' E. A. Padlan, E. W. Silverton, S. Sheriff The abbreviation used is: CDR, complementarity determining region. CDRs 1, 2, and 3 for the light chain are referred to as L1, L2, and L3 and for the heavy chain as H1, H2, and H3.
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light chain of NC41. Not all CDRB, however, contribute equal numbers of contacting residues. In D1.3 H3 contributes a preponderance of the interactions with lysozyme, but in HyHEL-5 L3 and H2 contribute the most contacts. In addition to the CDRB there are several framework residues that play a role in binding, for example H-Thrso and L-Tyr"g in D1.3 and H-np" in HyHEL-5.
Surface Complementarity
Perhaps the most striking feature of these analyses of antigenantibody complexes is the high degree of complementarity exhibited between the two interacting surfaces (see Fig. 1 for the docking of the HyHEL-5 and lysozyme). In the three cases where the structures have been partially refined, D1.3, HyHEL-5, and HyHEL-10, this complementarity is demonstrated by the almost complete exclusion of water from the interface, implying that any cavities that exist between the two surfaces are mostly too small to accommodate a water molecule. This complementarity extends over an area of about TABLE I Three-dimensionally determined epitopes of lysozyme Molecular surface areas were calculated from the coordinates for each of the structures using the programs MS, MSSEP, and MSAV (45). D1.3:
Asp'", Asn", kg1, Gl?' , TyP, SeP, Leum, Asn"
Lys"' , Gly"'
Thr"" , A spl", Val", Gln"', ne*, LeulaS Molecular &face area: 690 A' Gln4', Thru, As#, Arp, Asn", Thr", Asp", G~Y'~, l3@
GlF. ArP. Thrm, Prom LeUG -.
Molecular surface area: 750 A'
His", Gly", TyP, A r e TrpSS Arg' 3, Leu"
Th?, A m e 3 , Lyess, Lyss7, Ilese, Asplo', Gly102
Molecular surface area: 774 As HYHEL-10 750 A' , which is approximately 30% of the total surface area of the complementarity determining residues in the combining sites.
Charge Complementarity
In McPC603, the binding pocket for phosphocholine has a disposition of charged residues that complements the charge on the phosphocholine. At the back of the pocket there is L-Asp'l in contact with the positively charged choline together with H-Glu= which is near but not in contact. On the surface H -A r e makes hydrogen bonds with the phosphate group. This suggests that matching of the charges plays an important role in specificity. However, there are other ways of accommodating buried charges; for example, Quiocho et al. (19) have observed that in the bacterial binding proteins a sulfate ion can be buried inside the protein interior without having any charged amino acid side chain in contact with it, the charge neutralization being provided by dipole interactions from the amide NHs and from a-helices.
In the case of antibody-protein antigen interactions, HyHEL-5 provides the most striking example of charge neutralization. Two arginines that form a ridge on the surface of the lysozyme bind in a groove on the antibody, at the bottom of which there are two glutamic acid side chains, H-Glu= and H-G1uw. A number of charged residues is observed on the fringes of the contact surface that do not have contact with a residue of complementary charge. Here, where water can play a significant role in dissipating the charge effects, the formation of salt bridges is not required. In HyHEL-10, one salt bridge, between Lyew of lysozyme and H-Asp" of the Fab, is observed, but it is weak (closest distance between the residues is 3.6 A) and is located near the edge of the antibody-antigen interface.
Hydrogen Bonding
Hydrogen bonds that form in the interface also play a key role in the specificity of the interaction between the antibody and antigen. In a review of hydrogen bonds in proteins, Baker and Hubbard (20) note that not all possible hydrogen bonds between donors and acceptors are actually made. The game appears to be true with the interface in the antibody-antigen complexes, although the resolution of the xray data is probably not sufficient to establish the complete hydrogen bond system with certainty. The observation that conversion of A r p to Lys as in bobwhite quail lysozyme (21) lowers the affinity to HyHEL-5 by a factor of 1O00, despite the like charge, suggests that other factors such as the specific hydrogen bond arrangement also play a significant role in binding.
Mobility, Acceesibility, and Antigenicity
Several studies have linked mobility to antigenicity (22-24). Protrusion or surface accessibility has also been proposed by others (25, 26) as likely to be a factor in determining antigenicity. To some extent these properties are themselvgs linked in that those regions that most protrude into the solvent are also likely to have the highest mobility. Alternatively, antigenicity may be unrelated to mobility and, as proposed by Benjamin et al. (27) , any part of the antigen surface that is accessible to antibody could be antigenic.
The three antibody-lysozyme crystal structures, since they involve epitopes that cover almost half of the lysozyme surface, provide an opportunity to examine antigenicity in three-dimensional terms (Fig.  2) . First, it is clear that none of the three antibodies binds to a single continuous polypeptide segment, but are all directed to discontinuous epitopes. Indeed, as previously pointed out by several authors (28, 29) , a consideration of the relative sizes of the antibody combining site and the continuous segments on lysozyme make it improbable that there will be many antibodies to epitopes that consist solely of a single segment of chain. However, in each of these cases there are continuous oligopeptide sequences of varying lengths that make up part of the epitope. The epitopes for D1.3, HyHEL-5, and HyHEL-10 are compared in Fig. 3 with the mobility and accessibility of FIG. 1. Docking of ~ysozme to the HymL-5 Fab. The ca lysozyme. The results for mobility are rather inconclusive; there are representation of lysozyme is on the left in blue with its interacting regions of high mobility that form part of the epitope but so do several surface purple. The HyHEL-5 Fab is on the fight 6 t h the light chain regions of low mobility. The COrrehtiOn with regions Of high aCCeSSiin green and the heavy chain in orange and its interacting surface in bility is quite good, although here to0 there are residues Of low blue. The top image shows the two molecules 15 A apart, the middle accessibility that form contacts with antibody. Although the data are image shows the two molecules 7.5 A apart, and the bottom image limited, they would appear to support the conclusion of Benjamin et shows the two molecules as they are observed in the crystal. d (27) that all accessible regions are potentially antigenic.
FIG. 2.
Approximate surfaces of the three epitopes on lysozyme. The HyHEL-5 epitope is shown in red, the HyHEL-10 epitope in yellow, and the D1.3 epitope in magenta. Lysozyme is shown in blue with backbone atoms for noninteracting residues and the complete residue for those involved in any of the three epitopes.
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FIG. 3.
Average main-chain B-factor for tetragonal lysozyme and smoothed large probe accessibility for tetragonal lysozyme v e r~u s residue number. Also plotted are the residues involved in the epitopes of the three lysozyme-anti-lysozyme complexes. The large probe accessibility was smoothed by summing over 7 residues the accessibility weighted by a ramp function.
Epitope Mapping
Several methods have been used for defining the antigenic sites on a protein antigen. For lysozyme a library of avian lysozymes having similar three-dimensional structure to chicken lysozyme, but differing from it by a few amino acids, has been used to map the residues that contribute to the binding. The x-ray results can be compared with these predictions. For HyHEL-5 and for D1.3 the predicted epitopes were reasonably correct, although the amino acid differences on which the epitope was based, usually involving only 1 or 2 residues, cannot precisely define the whole epitopic surface, which usually consists of 15 residues. The epitope mapping for HyHEL-10, although it correctly identified part of the antigenic site, did not locate the center of the epitope. This was partly because the epitope for HyHEL-10 crosses the active site groove of lysozyme and involves residues that are part of the saccharide binding site and are therefore conserved in the different lysozymes with the result that no amino acid differences existed to identify this region of the epitope. In this case the natural abundance of evolutionary variants of a particular antigen was not sufficient to correctly identify the complete antigenic determinant. However, cloning and site-directed mutagenesis could provide ample mutants to circumvent this difficulty. Another reason that the mapping was incomplete for HyHEL-10 was a breakdown of the assumption that significant amino acid changes in the epitope would lead to significant changes in the observed binding between antibody and is aspartate in chicken lysozyme and is glycine in turkey lysozyme.
In competition binding experiments there was less than a 2-fold difference (which was not considered significant) between the two lysozymes, so it was considered unlikely that residue 101 was involved in the HyHEL-10 epitope (30) . More recent experiments with sitedirected mutants, Asp"' + Arg or + Lys, do show significant differences in binding, but they are smaller than the 1000-fold decrease in affhity of bobwhite quail lysozyme (Argea + Lys) for the In addition to the method described above there have been many other attempts to define the antigenic regions of lysozyme. The integrity of the three-dimensional structure is necessary since there is little or no cross-reactivity between native and denatured lysozymes (31). There has been extensive use of peptides in binding studies to the antibodies (reviewed in Refs. 28 and 32). Peptides from lysozyme that have been shown to be antigenic include the "N-C peptide" consisting of peptides 1-27 and 123-129 linked by a disulfide bond between Cys' and Cys"', the fragment 60-83 with a disulfide link between CysM and Cysm, the fragment 38-54, and peptides 62-68 and 74-96 linked by two disulfide bonds. The epitope for D1.3 antibody is essentially the N-C peptide; that for HyHEL-5 antibody consists mainly of parts of the antigenic fragments 60-83 and 38-54; and that for HyHEL-10 includes some of the residues in the peptides 62-68 and 74-96.
Using a variety of techniques, including chemical modifkation of selected residue types, Atassi and co-workers (33) have proposed that the entire antigenic structure of native lysozyme consists of three sites: Site I contains residues 5,7,13,14, and 125; Site 11 has residues 33, 34, 113, 114, and 116; and Site I11 has residues 62, 87, 89,93, 96, and 97. Site I11 includes some parts but not all of the HyHEL-10 epitope, and Site I1 includes 1 of the 16 residues in the D1.3 epitope.
The HyHEL-5 epitope, however, does not contain any of these amino acid residues. These three proposed sites clearly do not represent the entire antigenic structure of this antigen. Since the three antibodylysozyme complexes fortuitously cover approximately half the surface area of lysozyme, it would seem very likely that with enough antibodies the entire accessible surface of lysozyme will be shown to be antigenic.
Conformational Change
The combination of antibody and antigen could take place with no conformational change so that the two proteins would interact in a manner similar to the "lock-and-key" mechanism originally proposed by Fischer (34) to describe the interaction of a substrate with an enzyme. Here both the antibody and antigen would behave as if rigid. Their surfaces would complement one another prior to binding so that there would be no necessity for conformational change in either. Alternatively, there could be some conformational change as a result of binding, involving some degree of "induced fit" (35, 36) . The kinds of induced fit that might occur could range all the way from readjustment of side groups without moving the backbone atoms through movement of the hypervariable loops to major movement of the two variable domains of the antibody relative to one another. It seems very likely that some changes will occur when the antibody and antigen surfaces are brought together since when the same protein crystallizes in different crystal forms some differences in the side chain positions are usually observed due to different interactions with neighboring molecules, although the backbones usually remain the same to within experimental error. Cross-reactivity studies with peptides also suggest that some significant conformational change in the antigen accompanies binding (37, 38) .
In the four antibody-antigen structures discussed here, different degrees of conformational change have been observed. Since in none of these cases has the uncomplexed antibody structure been examined, the conclusions have been for the most part restricted to changes in the antigen, although in one case a tentative suggestion has been made that changes might be occurring in the antibody structure as a result of antigen binding (18). Amit et al. (15) observe in the D1.3 complex that the backbone of lysozyme is unchanged by complexation with the Fab, although some side chains do rearrange from the isolated lysozyme in its various crystal forms. In the other two lysozyme-anti-lysozyme Fab structures antigen. Residue-101, which is at the edge ofthe HyHEL-10 eGtope, L. Kam-Morgan and S. J. Smith-Gill, personal communication.
we find that there have been some small but significant changes in the structure of lysozyme. In the lysozyme-HyHEL-5 Fab complex Pro7' which is located in a mobile part of the uncomplexed lysozyme has moved toward the center of the molecule, with the Ca moving about 1.7 A. Another curious change that occurs in the HyHEL-5
Fab-lysozyme complex is a rotation of the side chain of Trp63 by 180 about its C&Cy bond despite the apparent lack of interaction of the antibody with this region of the lysozyme. In the HyHEL-10 complex there is movement of the lysozyme in the region of Asp'o', with the carbonyl oxygen of this residue moving by about 2.5 A. In addition, Trp6' in this complex appears to have undergone a large rotation about the Cp-Cr bond, presumably as a result of the interaction with the antibody. In the NC41-neuraminidase complex Colman et al. (18) note that there is also some rearrangement of part of the neuraminidase in the region of the epitope, with one of the surface loops showing shifts of up to 1 8, in the backbone atoms.
In the antibody also, some conformational changes probably occur, but because there are no crystals of the uncomplexed antibody they have not been directly observed. The antibody combining site is perhaps more likely to change than a compact rigid protein such as lysozyme. It contains six hypervariable loops, some of which in particular antibodies extend into the solvent and have disordered structures, as in L1 of McPC603 (39) . In addition, the combining site is constructed by bringing together two domains, VH and VL, that are joined by noncovalent forces. It has been previously noted that since a sylificant number of the residues in the interface are hypervariable residues, they could modulate the positions and orientations of VH relatiw to VL and in this way change the specificity of the binding site (reviewed in Ref. 2). Colman et al. (18, 40) have proposed that the binding to antigen also could produce movement of VH relative to VL in a way that would increase the complementarity of the antibody for the antigen.
Another way in which conformational changes in the antibody may occur is by the movement of individual hypervariable loops relative to the framework part of the domain structure. A comparison between the structures of HyHEL-5 and 5539, which have close sequence similarities, suggests that changes of this sort may have occurred here. The loops L1, H2, and H3 in HyHEL-5 do not adopt the conformations seen in 5539, and they could not do so without resulting in improper contacts with the lysozyme. Here too the structure of the uncomplexed Fab will be needed to prove that this change was the result of lysozyme binding.
In summary, even with only four examples, we already see a spectrum of effects ranging from a "lock-and-key'' model for the backbone of the antigen in the D1.3 Fab lysozyme complex to clear examples of locally "induced fit" in the case of the HyHEL-5 and HyHEL-10 Fab-lysozyme complexes and the NC41 Fab-neuraminidase complex. It seems likely that with less rigid antigens we shall observe even larger deformations than we have seen in our small sample to date. For the antibody, particularly where there are large insertions in some of the hypervariable loops so that these become inherently floppy and cannot be structurally defined from the electron density, the likelihood of conformational change seems to be quite high when the loop comes into contact with the antigen. An example of this kind of change occurs in the aspartic proteinases when they bind to inhibitors (41).
The Elbow Bend and Flexibility
The "elbow b e n d of the Fab, that is the angle between the pseudodyad axes of the variable and constant modules, has been known from the earliest Fab structures to vary considerably between different antibodies. Based on current studies of 15 Fabs, this parameter can vary from 132" to 172" (see Table I of Ref. 42) . It has been proposed (43) that changes in the elbow bend may signal antigen binding. Alternatively, the observed differences are nothing more than an expression of the flexibility of the antibody molecule at the juncture between the VLVH and the CLCHI modules. Recently there have been two reports of Fabs, , where the same Fab has been observed to have two different elbow bend angles. The HyHEL-5 Fab-lysozyme complex crystallizes in several closely related crystal forms, differing principally in the length of the b-cell axis. In the two forms for which data have been collected the difference in the elbow bend was 7". JEL 42 Fab crystallizes with two molecules in the asymmetric unit with a difference in the elbow bend angle of 8". These results and examination of Table I of Ref. 42 showing that there is no correlation between hapten or antigen binding and elbow bend angle strongly suggest that the different elbow bend angles observed are in fact simply due to flexibility.
